voice search
Lenvima Capsule - Receptor Tyrosine Kinase Inhibitor For Advanced Rcc Treatment | Effective Combination With Everolimus

Lenvima Capsule - Receptor Tyrosine Kinase Inhibitor For Advanced Rcc Treatment | Effective Combination With Everolimus

Price:

Get Latest Price

In Stock

In Stock

Product Specifications

Capsule Size10mg, 4mg
Dosage FormCapsules
PackagingBlister packs
Daily Dose24mg
Supply Duration30 days
Active IngredientLenvatinib
Route Of AdministrationOral
FeaturesCancer treatment, RTK inhibitor, Daily dose, 30-day supply, Effective therapy, Combats RCC, Advanced RCC

Product Overview

Key Features

Due of our extremely talented team of professionals, we are engaged in exporting and distributing an excellent quality Lenvima Capsule in Palghar, Maharashtra, India.

Lenvima (lenvatinib) is a receptor tyrosine kinase (RTK) inhibitor that inhibits the kinase activities of vascular endothelial growth factor (VEGF) receptors VEGFR1 (FLT1), VEGFR2 (KDR), and VEGFR3 (FLT4).

Lenvima is specifically indicated for use in combination with everolimus for the treatment of patients with advanced RCC following one prior anti-angiogenic therapy.

Company Details

company name: Maxheal Pharmaceutical Pvt Limited contact person: Jiten Aggarwal Address: H.301 Maxheal house, tarapur industrial area, Dist Palghar 401506, Maharashtra.

Business Type

Exporter, Distributor

Employee Count

100

Establishment

1987

Working Days

Sunday To Sunday

Payment Mode

Western Union

Related Products

Explore Related Categories

More Products From This Seller

Seller Details

Palghar, Maharashtra

Seller Inquiry

Accepts only Foreign inquiries

Name

Jiten Aggarwal

Address

Address: H.301 Maxheal house, tarapur industrial area, Dist. Palghar, Maharashtra, 401506, India

pharmaceutical capsules in Palghar

Report incorrect details

Compare With Similar Products

People Also Viewed